GrandPharma (China) Co., Ltd.
GrandPharma (China) Co., Ltd.
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Yttrium [90Y] Microsphere Injection in Combination With Targeted Immunotherapy in the Treatment of HCC | hepatocellular carcinoma | Recruiting | Phase 2 | 2026-01-12 | NCT07334483 | |
| 68Ga-GP-01 Injection in Solid Tumors Participants | Solid Tumor Malignancies | Not yet recruiting | Phase 1 | 2025-07-03 | NCT07045428 | |
| Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Enrolling by invitation | Not stated | 2024-12-05 | NCT06712017 | |
| Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Not yet recruiting | Not stated | 2023-10-13 | NCT06079242 |